Aspect Biosystems
10 known investors
Aspect Bio Systems develops bioprinted tissue therapeutics for regenerative medicine using a platform that combines AI-powered bioprinting, computational design, therapeutic cells, and biomaterials. The company targets metabolic and endocrine diseases by creating implantable tissues for replacement, repair, or supplementation of biological functions.
Investors · 10
Angel ForumVancouvervia Irene Dorsman · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
InBC Investment Corp.British Columbia · $3M – $10M
JDRF T1D FundBoston
Page One VenturesSilicon Valley
Pallasite VenturesVancouver · $100K – $1.5M
Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M
Radical VenturesToronto · $1M – $25M
Rising TidePacifica
Dimension CapitalreportedSan Francisco · $1M – $10M